For children affected by T1DM with a clinical onset from 1 to 5 years, IA2 antibodies were more frequently positive (77.8%), followed by anti-GAD (69.4%) and finally by anti-IAA (58.3%). The gene discussed is GAD1; the disease is type 1 diabetes mellitus.